LEE'S PHARM 00950·

Gross margin 63.68%--62.50%1.18%52.35%10.15%53.81%1.46%50.81%3.01% Net margin 154.79%--3.72%151.07%1.89%1.82%4.90%3.01%3.52%1.38% ROE 80.63%--2.67%77.96%0.82%1.85%5.64%4.82%4.49%1.14% ROA 53.89%--1.65%52.24%0.69%0.96%2.62%1.93%1.46%1.16% Revenue growth ----6.41%---13.37%19.77%35.85%49.22%0.04%35.81% Attributable profit growth -----97.18%---66.97%30.21%469.74%536.71%-3.68%473.42% Debt-to-assets 34.25%--33.77%0.48%32.17%1.60%40.83%8.66%45.14%4.31% Current ratio 1.04--1.000.041.010.011.020.011.030.02 Operating cash flow / net profit 0.11--6.196.085.520.673.531.996.583.05 Operating cash flow / revenue 16.64%--23.00%6.36%10.45%12.55%17.29%6.83%23.18%5.90%

Gross margin 51.82%--56.17%4.35% Net margin 7.27%--7.89%0.62% Revenue growth ----14.64%-- Attributable profit growth ----41.42%-- Debt-to-assets ----44.11%-- Current ratio ----1.06-- Operating cash flow / net profit 3.65--3.730.08 Operating cash flow / revenue 26.53%--29.45%2.92%

Revenue 1.04B--1.10B6.41%954.28M13.37%1.30B35.85%1.30B0.04% Other income and gains 83.66M--65.86M21.27%70.01M6.30%57.83M17.40%45.77M20.86% Gross profit 659.22M--688.49M4.44%499.61M27.43%697.64M39.64%658.95M5.54% Selling and distribution expenses 299.60M--309.49M3.30%275.76M10.90%358.65M30.06%301.66M15.89% Administrative expenses 243.04M--177.24M27.08%170.92M3.56%180.85M5.81%201.40M11.36% Net finance costs 4.68M--6.78M45.02%10.78M58.93%13.14M21.87%10.14M22.84% Income tax 7.75M--19.68M153.79%9.82M50.09%27.32M178.20%20.11M26.37% Operating profit 1.62B--68.39M95.77%39.47M42.29%104.77M165.46%77.64M25.90% Share of associates and JVs -2.86M---986.17K65.49%-788.41K20.05%-776.95K1.45%-1.67M114.72% Profit before tax 1.61B--60.62M96.24%27.90M53.98%90.86M225.67%65.83M27.54% Net profit 1.60B--40.94M97.44%18.08M55.85%63.54M251.46%45.72M28.05% Net profit attributable to owners 1.62B--45.81M97.18%15.13M66.97%86.21M469.74%83.04M3.68%

Revenue 694.82M--796.57M14.64% Other income and gains 16.32M--170.09M942.32% Cost of sales 334.77M--349.12M4.29% Gross profit 360.05M--447.45M24.27% Selling and distribution expenses 152.58M--180.46M18.27% Administrative expenses 101.60M--186.14M83.21% Net finance costs 6.35M--5.75M9.49% Income tax 10.13M--23.60M132.98% Operating profit 67.52M--93.60M38.64% Share of associates and JVs -488.00K---1.39M185.04% Profit before tax 60.67M--86.46M42.50% Net profit 50.55M--62.86M24.37% Net profit attributable to owners 67.19M--95.01M41.42%

Cash and cash equivalents 226.91M--169.10M25.48%154.96M8.36%200.81M29.58%316.03M57.38% Trade and bills receivables 137.62M--99.40M27.77%76.66M22.88%149.18M94.61%172.25M15.46% Inventories 270.95M--222.62M17.84%270.15M21.35%266.25M1.44%329.16M23.63% Total current assets 787.61M--582.09M26.09%595.05M2.23%726.56M22.10%1.06B45.36% Total assets 2.97B--2.49B16.43%2.62B5.41%2.42B7.46%3.13B29.06% Total current liabilities 754.30M--580.72M23.01%587.97M1.25%714.21M21.47%1.02B42.93% Total liabilities 1.02B--839.23M17.60%842.85M0.43%989.90M17.45%1.41B42.67% Equity attributable to owners 2.02B--1.72B14.70%1.85B7.51%1.53B17.22%1.85B20.80% Total equity 1.96B--1.65B15.81%1.78B7.95%1.43B19.27%1.72B19.66%

Cash and cash equivalents ----364.39M-- Trade and bills receivables ----215.70M-- Inventories ----420.99M-- Total current assets ----1.21B-- Total assets ----3.48B-- Total current liabilities ----1.13B-- Total liabilities ----1.54B-- Equity attributable to owners ----2.13B-- Total equity ----1.95B--

Net cash from operating activities 172.25M--253.36M47.09%99.76M60.63%224.11M124.66%300.69M34.17% Net cash from investing activities -302.74M---228.72M24.45%-131.60M42.46%-176.16M33.86%-212.95M20.88% Net cash from financing activities 49.85M---114.87M330.42%12.18M110.60%-1.81M114.90%32.14M1871.63% Net change in cash -80.64M---90.23M11.90%-19.66M78.21%46.14M334.65%119.88M159.83%

Net cash from operating activities 184.31M--234.56M27.26% Net cash from investing activities -86.34M---146.72M69.94% Net cash from financing activities -5.69M---76.11M1237.92% Net change in cash 92.29M--11.73M87.29%